Livingstone’s Healthcare sector team has advised the shareholders of Spiegelberg (GmbH & Co.) KG on the sale of the business to investor group SHS GmbH.
Spiegelberg is a leading medical devices manufacturer based in Hamburg, Germany. Founded in 1986 by Dr. Andreas Spiegelberg, the company develops and supplies medical equipment for the monitoring of intracranial pressure, which is distributed in over 40 countries.
SHS is a specialist Healthcare and Life Sciences sector investor managing a €120m growth capital fund.
Close collaboration between the Livingstone teams in London and Düsseldorf brought this deal to a successful conclusion.
Jochen Hense, Managing Partner at Livingstone Düsseldorf added: “We strongly believe that with SHS we found the best possible investor who will support the future internationalisation strategy of the company and at the same time agreed upon favourable and fair contractual terms with the sellers and management, which will stay with the company post closing.”
Closely following on from The GADA Group growth recapitalisation earlier this month, this deal further reinforces Livingstone’s growing record in the medical devices space, having completed six transactions across Healthcare sector in 2011 so far.